In a patient who has had several falls in the last few weeks, which selective serotonin reuptake inhibitor (SSRI) has the lowest fall‑risk profile?

SSRI with Lowest Fall Risk in Elderly Patients with Recent Falls

Based on the available evidence, there is no single SSRI that can be definitively recommended as having the lowest fall risk profile, as all SSRIs are independently associated with increased fall risk in older adults. However, if an SSRI must be used, the evidence suggests avoiding citalopram specifically, as it was the only individual SSRI significantly associated with falls in a large elderly cohort 1.

Understanding the Fall Risk with SSRIs

All SSRIs carry an inherent fall risk in older adults that appears independent of the underlying depression:

• SSRIs as a class increase fall risk by 58% (HR 1.58) in community-dwelling elderly 1
• This association persists even after adjusting for residual depressive symptoms, indicating the risk is medication-specific, not just depression-related 1
• The risk increases with duration: continuing SSRI treatment over 4 years increases fall risk by 80% 1
• Dose-response relationship exists: even at 0.25 of the defined daily dose, fall risk increases by 31%, rising to a 198% increase at full dose 2

Individual SSRI Considerations

Among specific SSRIs studied:

• Citalopram: The only SSRI with statistically significant association with falls in elderly populations 1. Also carries QT prolongation risk, particularly concerning in older adults 3
• Fluoxetine: Associated with fractures but not specifically with falls 1
• Sertraline: Associated with discontinuation syndrome 3 but no specific fall data distinguishing it from other SSRIs
• Paroxetine: Should generally be avoided in older adults due to higher anticholinergic effects and sexual dysfunction 4, plus discontinuation syndrome 3

Critical Risk Amplification

The combination of SSRI use with frailty substantially amplifies fall risk beyond either factor alone 5. This is particularly important because:

• Frailty is more prevalent among SSRI users (44.8% vs 33.7%) 5
• Concurrent SSRI use and frailty increases fall risk substantially above either factor alone 5
• In contrast, concurrent SSRI use with non-remitted depression does not increase risk beyond either factor alone 5

Practical Clinical Algorithm

For a patient with recent falls requiring antidepressant treatment:

1. First-line: Consider non-SSRI alternatives

   • SNRIs (particularly venlafaxine) show lower fall risk than SSRIs 6, 7
   • Bupropion has favorable side effect profile with lower sexual dysfunction 8

2. If SSRI is necessary:

   • Avoid citalopram (specific fall association) 1
   • Avoid paroxetine (anticholinergic burden in elderly) 4
   • Consider fluoxetine or sertraline, but recognize all SSRIs carry fall risk
   • Start at lowest possible dose (even 0.25 DDD increases fall risk by 31%) 2
   • Titrate extremely slowly given dose-response relationship 2

3. Essential monitoring:

   • Assess frailty status using validated tool (FRAIL questionnaire) 5
   • If frail, strongly reconsider SSRI use entirely
   • Monitor closely in first weeks when behavioral activation/agitation risk is highest 3
   • Evaluate for concurrent medications that increase fall risk (benzodiazepines, antipsychotics) 9

Important Caveats

• Drug interactions matter: Citalopram/escitalopram have the least CYP450 effects and lowest propensity for drug interactions 3, which may be relevant in polypharmacy situations despite citalopram's fall association
• Discontinuation syndrome: Paroxetine, fluvoxamine, and sertraline are associated with discontinuation syndrome characterized by dizziness, imbalance, and vertigo—all fall risk factors 3
• The 2019 AGS Beers Criteria added SNRIs to the list of antidepressants to avoid in persons with history of falls 6, indicating the problem extends beyond SSRIs alone

Bottom line: In a patient with recent falls, the safest approach is to avoid SSRIs entirely if possible. If depression treatment is essential, consider psychotherapy (CBT shows equivalent efficacy to SSRIs) 10, or non-SSRI antidepressants. If an SSRI must be used, avoid citalopram and paroxetine specifically, use the lowest effective dose, and implement intensive fall prevention strategies.